HomeHealthcare & Life SciencesPharmaceuticals Metformin Hydrochloride Market

South Korea Metformin Hydrochloride Market Size & Outlook, 2025-2033


South Korea Metformin Hydrochloride Market Insights

  • As per Reed Intelligence insights, the South Korea Metformin Hydrochloride Market stood at USD 285.26 Million in 2024 and is anticipated to grow to USD 508.7 Million by 2033.
  • The South Korea market is expected to advance at a CAGR of 6.67% from 2026 through 2033.
  • In 2024, Type 2 Diabetes accounted for the highest share of the By Indication market size.
  • During the forecast period, Polycystic Ovary Syndrome is set to register the highest growth, making it the most lucrative By Indication segment.

Other Key Findings


  • South Korea accounted for 1.42% of the global Metformin Hydrochloride Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Metformin Hydrochloride Market size by 2033.
  • Australia will be the fastest-growing market in Asia Pacific, projected to achieve USD 470.93 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 285.26 Million
Market Size In 2033 USD 508.7 Million
Largest segment Type 2 Diabetes
Units Revenue in USD Million
CAGR 6.67% (2025-2033)
Segmnetation Covered
By Indication
  1. Type 2 Diabetes
  2. Gestational Diabetes
  3. Polycystic Ovary Syndrome
Form
  1. Tablets
  2. Extended-Release Tablets
  3. Oral Solutions
  4. Injectable Solutions
Route of Administration
  1. Oral
  2. Intravenous
Distribution Channel
  1. Retail Pharmacies
  2. Hospital Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports